ARCHIVES

Two Drugs Slow Progress Of Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

New Subcontracts Planned In Bioassay Program Run by Traco-JITCO

May 23, 1975

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978

Funding Opportunities.

May 24, 2002

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

May 12, 2000

Funding opportunities listed.

June 25, 2004